China

Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29

Share

Share - WeChat

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo

Beijing launches program to foster international entrepreneurship

Tianjin's Hangu Salt Field marks 1,100th anniversary

Ten photos from across China: Oct 31 - Nov 6

Bird-watching festival in Yunnan unveils new discoveries

County in Heilongjiang dazzles with rare rime ice scenery

Blizzard hits Xinjiang in NW China

Latest

State Council News

China’s public holidays for 2026

Exclusive

Key words from Party recommendations document

Sneak peek: Warm-up show for National Games opening

Party plenum: Charting the course for the 15th Five-Year Plan period (2026-30)

Newsmaker

Transport aircraft pilot flies high in PLA

Zimbabwean physician acts as ambassador for TCM

Ten photos you don't wanna miss

Ten photos from across China: Oct 31 - Nov 6

Special Coverage

4th Plenary Session of the 20th CPC Central Committee

Celebrating 70 years of progress in Xinjiang

BACK TO THE TOP

English

中文

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

About China Daily

Advertise on Site

Expat Employment

FOLLOW US